Also found in: Medical, Wikipedia.
CCR2C-C Chemokine Receptor 2 (gene)
References in periodicals archive ?
reported that soluble UL128 protein (1000 ng/mL) in vitro could block migration of monocytes by down-regulation of CCR1, CCR2 and CCR5 comparing with monocytes infected with wild type of HCMV.
Macrophages without CCR2 originate in the heart; those with CCR2 come from the bone marrow, the research showed.
Effect of Genetic Variants of CCR2 and CCL2 on the Natural History of HIV-1 Infection CCL2-2518GG Is Overrepresented in a Cohort of Spanish HIV-1Infected Subjects.
The company's lead product, cenicriviroc, is a first in class immumodulator and dual inhibitor of CCR2 and CCR5 being evaluated for the treatment of nonalcoholic steatohepatitis and HIV.
Identification of single nucleotide polymorphisms in the bovine CCL2, IL8, CCR2 and IL8RA genes and their association with health and production in Canadian Holsteins.
There is ample evidence that allele frequencies and relative hazard values of the [DELTA]32 polymorphism of C-C chemokine receptor 5 (CCR5), the CCR5 promoter polymorphism P1, the 64I polymorphism of CCR2, T-cell receptor excision circles, Toll-like receptors 4 and 9, interleukin-7 receptor [alpha], and HLA homozygosity produce divergent patterns of progression to AIDS after infection (3-6).
Es importante rescatar que esta categoria tambien puede ser considerada un CCR1 o un CCR2, debido a que las explicaciones que brinde la persona consultante pueden mostrarse como un comportamiento problema o como una mejoria, dependiendo del caso (Ferro et al.
Levels of MCP-1, CCR2 mRNA and protein were temporarily elevated, and neuronal signaling activity increased in the DRG at eight weeks after surgery.
The company's lead independent drug candidate, CCX140, a CCR2 inhibitor, has been shown to be safe and well tolerated while demonstrating clinical activity on glycemic indices in a Phase II clinical trial in type 2 diabetics, and is now in Phase II clinical development for the treatment of diabetic nephropathy.
The telltale marker of immune system activity against beta-amyloid, a gene called CCR2, emerged as the top marker associated with memory in people.
Although the direct association between HPV infection and inflammation is controversial, transgenic mouse models, expressing the early genes from HPV 16 under the control of the human keratin 14 promoter, have shown that HPV-induced lesions release the chemokine CCL2 which enhances macrophage recruitment into tumours via CCR2.
Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression.